[gtranslate]

News

1767583663654

$100B Nuclear Medicine Star Target ACP3 Reshapes the Prostate Cancer Treatment Landscape

In recent years, the Onco...

1766985449032

CRBN-KO Can Still Show Drug Activity? This BTK Degrader Is Seriously Impressive

In previous articles, we ...

75f812c3d6e04dec8d3d29a6cbd72f09

The STEAP Protein Family: Transmembrane “Express Channels” and the Next Promising Targets in Cancer Therapy

In 2025, research on the ...

3513f3b364264ad490b1beb1632353d7

WRN-MutCell Platform: Empowering Precision Drug-Resistance Research · Driving Breakthroughs in Novel Therapeutics

Introduction At th...

1766163886387

Kyinno Biotechnology Announces USD 35M Series B Financing, Focusing on Dual/Multispecific Antibody Innovation

Artery Network learned at...

1766118963787

Dual-Target ADC Achieves “1+1>2” Synergistic Killing: Four Core Dimensions Are Key

The “1+1>2” effect of ...

f30c4da319b24f478dc56db3bff8e80b

The “Golden Duo” of Cancer Immunotherapy: PD-1 & IL-2 Dual-Target Reporter Cells

The “Golden Duo” o...

1765778766257

ASGR1 Overexpression Cell Lines Drive IgA Nephropathy and Breakthroughs in Multidisciplinary Drug R&D

IgA nephropathy (IgAN), t...

1763999113764

World’s 1st Bio-Thera’s EGFR/HER3 Bispecific ADC Succeeds in Phase III: Kyinno’s Common Light Chain Mouse Platform Supports Bispecific ADC Development

On July 2, 2025, Bio-Ther...

1765170688218

Rapid Tracking, Precise Degradation: ESR1-HiBiT-KI Cell Line Breaks Through the Challenge of Breast Cancer Drug Resistance

Recently, there has been ...